For every lead compound developed in medicinal chemistry research, numerous other inactive or less active candidates are synthetized/isolated and tested. The majority of these compounds will not be selected for further development due to a sub-optimal pharmacological profile. However, some poorly active or even inactive compounds could live a second life if tested against other targets. Thus, new therapeutic opportunities could emerge and synergistic activities could be identified and exploited for existing compounds by sharing information between researchers who are working on different targets. The Mu.Ta.Lig (Multi-Target Ligand) Chemotheca database aims to offer such opportunities by facilitating information exchange among researchers wo...
The traditional work of a natural products researcher consists in large part of time-consuming exper...
Abstract: ChemVassa, a new chemical structure search technology, was developed to allow rapid in sil...
At the dawn of the 21st century, human genetic sequencing in combination with computationally-enable...
For every lead compound developed in medicinal chemistry research, numerous other inactive or less a...
For every lead compound developed in medicinal chemistry research, numerous other inactive or less a...
Motivation: The development of chemoinformatics has been hampered by the lack of large, publicly ava...
Motivation: The development of chemoinformatics has been hampered by the lack of large, publicly ava...
gets. In this paper, we present a brief overview of many Target, chemical and bioactivity informatio...
Cheminformatics has emerged as an applied branch of Chemistry that involves multidisciplinary knowle...
The drug discovery process is supported by a multitude of freely available tools on the Internet. Th...
Publicly available compound and bioactivity databases provide an essential basis for data-driven app...
<p>Databases that provide links between bioactive compounds and their protein targets are increasing...
The enormous increase in the amount of publicly available chemical genomics data and the growing emp...
Elucidation of the mechanistic relationships between drugs, their targets, and diseases is at the co...
ChemBioServer 2.0 is the advanced sequel of a web server for filtering, clustering and networking of...
The traditional work of a natural products researcher consists in large part of time-consuming exper...
Abstract: ChemVassa, a new chemical structure search technology, was developed to allow rapid in sil...
At the dawn of the 21st century, human genetic sequencing in combination with computationally-enable...
For every lead compound developed in medicinal chemistry research, numerous other inactive or less a...
For every lead compound developed in medicinal chemistry research, numerous other inactive or less a...
Motivation: The development of chemoinformatics has been hampered by the lack of large, publicly ava...
Motivation: The development of chemoinformatics has been hampered by the lack of large, publicly ava...
gets. In this paper, we present a brief overview of many Target, chemical and bioactivity informatio...
Cheminformatics has emerged as an applied branch of Chemistry that involves multidisciplinary knowle...
The drug discovery process is supported by a multitude of freely available tools on the Internet. Th...
Publicly available compound and bioactivity databases provide an essential basis for data-driven app...
<p>Databases that provide links between bioactive compounds and their protein targets are increasing...
The enormous increase in the amount of publicly available chemical genomics data and the growing emp...
Elucidation of the mechanistic relationships between drugs, their targets, and diseases is at the co...
ChemBioServer 2.0 is the advanced sequel of a web server for filtering, clustering and networking of...
The traditional work of a natural products researcher consists in large part of time-consuming exper...
Abstract: ChemVassa, a new chemical structure search technology, was developed to allow rapid in sil...
At the dawn of the 21st century, human genetic sequencing in combination with computationally-enable...